Evofem Biosciences, Inc. (EVFM) Financials
EVFM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 10.6 million | 77.1 million |
2023-09-30 | 13.3 million | 67.9 million |
2023-06-30 | 14.1 million | 69.7 million |
2023-03-31 | 25.2 million | 97.0 million |
EVFM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -170000 | 246000 |
2023-09-30 | -2.4 million | 258000 |
2023-06-30 | -1.5 million | 268000 |
2023-03-31 | -6.6 million | 183000 |
EVFM Net Income
No data available :(
EVFM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 105000 |
2023-09-30 | -151000 | - | 151000 |
2023-06-30 | 19.9 million | - | 195000 |
2023-03-31 | 2.8 million | - | 4.9 million |
EVFM Shares Outstanding
EVFM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.4 million | 5.9 million | - |
2023-09-30 | - | 614000 | 3.2 million | 3.0 million |
2023-06-30 | 1000 | 402000 | 4.9 million | 2.2 million |
2023-03-31 | 35000 | 1.7 million | 3.2 million | 7.0 million |
EVFM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 4.8 million | 954000 |
2023-09-30 | 5.1 million | 1.9 million |
2023-06-30 | 2.5 million | 2.3 million |
2023-03-31 | 181000 | 384000 |
EVFM
Price: $0.01
52 week price:
Earnings Per Share: 38.97 USD
P/E Ratio: -0.02
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 2.6 million
Ebitda: -1.8 millionMarket Capitalization: 769486